UNSPSC 51111913: Paclitaxel ceribate

This classification denotes a taxane compound and taxane-site binding agent C51H57NO18, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B3C86E80A0, chemically known as 7.beta.-((2rs)-2,3-dihydroxypropoxycarbonyloxy)-1-hydroxy-9-oxo-5.beta.,20-epoxytax-11-ene-2.alpha.,4,10.beta.,13.alpha.-tetrayl 4,10-diacetate 2-benzoate 13-((2r,3s)-3-benzamido-2-hydroxy-3-phenylpropanoate), but more generally known as paclitaxel ceribate, which bears US NIH Compound Identifier 16760673.

UNSPSC 51111913 Paclitaxel ceribate, a Commodity code, names a specialized pharmaceutical product — a paclitaxel derivative formulation — that state and local health systems and correctional facilities procure as part of oncology treatment protocols. The code reflects state and local demand for branded or generic chemotherapy agents, typically acquired through established pharmaceutical supply channels, group purchasing agreements, or direct procurement by state health departments and county hospital systems. Paclitaxel ceribate represents the narrowest tier of the UNSPSC taxonomy and applies to a single product line within the broader family of cancer-treatment pharmaceuticals.

The source provides no recent state and local contract opportunities under this Commodity code. Without posted solicitations, active RFPs, or awarded contracts in the most-recent-opportunities dataset, no issuing-body mix, geographic concentration, or representative procurement activity can be characterized. Absence of recent activity under this specific code does not indicate zero demand — paclitaxel and its derivatives remain standard oncology therapeutics — but rather that state and local procurement offices may tag chemotherapy acquisitions at a higher tier (such as a Family or Class code covering all cancer drugs or all pharmaceuticals) or conduct purchases through cooperative purchasing vehicles or GPOs that do not post individual notices. Confirm current activity through state health-department procurement offices and county hospital purchasing contacts directly.